Chris Sinclair

Chris Sinclair is an accomplished leader with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Vice-President of Global Therapeutics Platforms at AbbVie, Chris oversees a team of over 160 employees dedicated to fulfilling technology requirements across various R&D phases, including clinical trial operations and regulatory affairs. Previously, Chris held senior director roles within AbbVie, managing operations and compliance for a large-scale organization and developing business systems technology strategies for regulatory functions. Earlier in the career, Chris worked at Abbott, where responsibilities included leading global continuous improvement initiatives in drug development processes. Chris holds a PhD in Biochemistry and Molecular Biology from Purdue University and an MBA in Business Administration with a focus on strategic management from Indiana University’s Kelley School of Business.